fection. e transmission of Chagas´ disease primarily occurs by infection with the triatomine vector, but it also has been reported to result from blood transfusion, congenital transmission, organ transplantation, the ingestion of contaminated food and laboratory accidents [2] . Due to its anthropic action, the triatomine favours a domiciliary and peridomiciliary behaviour, increasing human exposure and risk of infection. A recent report stated that 8 million people in Latin America have this disease and described the major concern that immigration-related globalisation will bring infected people to non-endemic regions, such as Europe, North America and Australia [2] . e disease treatment is still based on benznidazole and nifurtimox, nitroderivatives that were empirically developed forty years ago and present important limitations, such as high doses, severe side e ects and controversial e cacy in chronic patients [3] . Intense e orts have been directed to discover new compounds against T. cruzi, better characterise their particular mechanisms of action and identify the molecules and pathways involved [4] .
Gene expression in trypanosomatids, including T. cruzi, is very unusual in that the open reading frames are arranged in long polycistronic arrays and monocistronic mRNAs are created by post-transcriptional processing. us, the regulation of gene expression in T. cruzi is mainly posttranscriptional [5] . Previous studies have revealed nontranslated mRNA in the T. cruzi cytoplasm [6] . erefore, the use of nucleic acid-based tools, such as RNA microarrays and PCR, to study gene expression is limited in trypanosomatids, and thus, the application of proteomic techniques is highly desirable.
Proteomics is a high-throughput approach that is extensively employed in structural and functional studies on the regulation of protein expression to validate genome annotations [7] . Di erent stage-speci c molecules and proteins associated with parasite drug resistance have been identi ed by proteomic approaches in T. cruzi [8] [9] [10] [11] , reinforcing the importance of these techniques in the selection of metabolic targets of new inhibitors or therapeutic drugs [2, 12] .
In the present study, we used two-dimensional electrophoresis (2-DE) and mass spectrometry to contribute additional information to the descriptive proteomic map of T. cruzi epimastigotes (Y strain). e Y strain is a natural strain of T. cruzi I that is found in Brazil and presents high parasitaemia and mortality in mouse models. Despite its virulence, the Y strain is susceptible to benznidazole treatment [13] . Here, T. cruzi samples analysed by 2-DE were stained with di erent dyes to reveal speci c phosphoproteins and glycoproteins, which were then identi ed by MS. e identi ed T. cruzi glycoproteins are particularly important as targets for therapeutic intervention, and our analysis of the phosphorylated proteins could provide crucial insights into the signalling networks that govern the metabolism of this parasite. e identi ed peptides and proteins were characterised using bioinformatic tools in an attempt to nd potential drug targets.
Materials and methods

Parasites and sample preparation
T. cruzi epimastigotes (Y strain) were maintained in liver infusion tryptose (LIT) medium at 28°C and harvested during exponential growth phase. e parasites were harvested by centrifugation, washed three times with phosphate buered saline (PBS, pH 7.4) and incubated in sample lysis solution (7 M urea, 2 M thiourea, 4% CHAPS, 40 mM Tris, 60 mM DTT, 1% ampholytes) containing the Complete Mini protease inhibitor cocktail (Roche Applied Science, Indianapolis, USA). e parasite cells were further disrupted via ten cycles of freezing in liquid nitrogen and thawing at room temperature, with gentle mixing between cycles, as previously described [11] . To obtain the soluble protein fraction, the cell lysate was centrifuged at 13,000 g for 30 min, and the protein content was determined using the 2D Quant kit (GE Healthcare, Buckinghamshire, England).
Two-dimensional electrophoresis and image analysis
Isoelectric focusing of the soluble protein fraction from the epimastigote extracts was performed using an IPGphor system (GE Healthcare) and 18-cm IPG strips of pH 4-7. e protein fraction was diluted in rehydration bu er (7 M urea, 2 M thiourea, 4% CHAPS, 60 mM DTT, 1% ampholytes and a trace amount of bromophenol blue) and loaded onto each strip. e strips were rehydrated for 12 h at 30 V and isoelectrically focused using the following protocol: 200 V/1 h, 500 V/1 h, 1000 V/1 h, a gradient of 1000 to 8000 V for 10 min and 8000 V/6 h. e strips were then equilibrated in 50 mM Tris-HCl (pH 8.8), 6 M urea, 30% v/v glycerol, 2% w/v SDS, 0.002% w/v bromophenol blue and 1% w/v DTT for 15 min, followed by a second 15-min incubation in the same bu er but with 4% iodoacetamide instead of DTT. Separation in the second dimension was performed by SDS-PAGE using 12% acrylamide gels at 2.5 W/gel for 30 min and then 100 W until completion using a DALTsix system (GE HealthCare). . e proteins separated on the 2D gels were stained to detect phosphoproteins, glycoproteins or total protein as described below.
Detection of total protein
Gels were xed three times with 30% ethanol and 2% phosphoric acid for 30 min per wash, followed by three successive washes in 2% phosphoric acid in water for 20 min.
en, the gels were incubated in 18% ethanol, 2% phosphoric acid and 15% ammonium sulphate for 30 min, followed by the addition of 2% Coomassie Brilliant Blue G in water (Sigma-Aldrich, St. Louis, USA). e gels were scanned and the spots were detected, quanti ed and analysed with Image Master Platinum so ware (GE Healthcare). Each spot was manually inspected and, when necessary, edited with the Edit Spot Tools to improve accuracy.
Detection of phosphoproteins
2D gels were xed in 50% methanol and 10% acetic acid overnight, washed three times with deionised water for 10 min per wash and incubated in Pro-Q Diamond phosphoprotein stain (Molecular Probes) for 90 min. To reduce the background signal, gels were destained with three successive washes of 20% acetonitrile and 50 mM sodium acetate (pH 4.0). Images were acquired with a Typhoon Trio system (GE Healthcare) using a 532 nm laser for excitation and a 580 nm lter for emission. Following image acquisition, the gels were stained with colloidal Coomassie as previously described for the detection of total protein to view and excise the protein spots that were revealed by this speci c staining.
Detection of glycoproteins
Pro-Q Emerald 488 (Molecular Probes) was used to detect glycoproteins in the 2D gels. Brie y, gels were xed with two changes of 50% methanol and 5% acetic acid for 1 hour per wash, followed by incubation in 1% periodic acid and 3% acetic acid for 1 hour to oxidise the glycans on these proteins. A er washing in 3% acetic acid, gels were incubated in a Pro-Q Emerald dye solution for 2 hours in the dark and washed again in 3% acetic acid to reduce the gel background. All steps were carried out at room temperature with gentle agitation, and the images were captured on a Typhoon Trio system using a 488 nm laser for excitation and a 520 nm lter for emission. Following image acquisition, as described above for Pro-Q Diamond staining, the gels were stained with colloidal Coomassie for the visualisation and excision of the protein spots revealed by the glycoprotein-speci c staining.
In-gel tryptic digestion, sample desalting and MALDI-TOF TOF spectrometry analysis
Coomassie-, Pro-Q-Emerald-and Pro-Q-Diamondstained spots were excised and digested as previously described with some modi cations [14] . Protein spots were excised from the gel and washed with a 1:1 (v/v) 50 mM ammonium bicarbonate (pH 8.0)/acetonitrile solution, followed by shaking for 15 min. is washing procedure was repeated with fresh solution until destaining was complete, and the gel was dehydrated by the addition of 200 µL of acetonitrile for 5 min. Each sample was then rehydrated with approximately 10 µL of ice-cold trypsin solution (20 ng/µL in 40 mM ammonium bicarbonate [pH 8.0]) and le on ice for 1 hour. e incubation was allowed to proceed for 16 h at 37°C
. A er the digestion, the peptides were extracted twice by the addition of 30 µL of 50% acetonitrile and 5% formic acid and transferred to 0.6 mL tubes. Each sample was concentrated in a vacuum centrifuge to a nal volume of 5-10 µL.
C18 ZipTip micropipette tips (Millipore, Bedford, USA) were used to desalt the peptides. e tips were rst activated with acetonitrile and then equilibrated with 0.1% tri uoroacetic acid (TFA) in water. e samples were aspirated and dispensed eight times, and the tips were washed 3-5 times with 0.1% TFA in water. e peptides retained in the tips were eluted with 1. Raw data for protein identi cation were obtained using the 4700 Proteomics Analyzer (Applied Biosystems, Foster City, CA). Both MS and MS/MS data were acquired in positive and re ectron mode using a neodymium-doped yttrium aluminium garnet (Nd:YAG) laser with a 200-Hz repetition rate. Typically, 1,600 shots were accumulated for spectra in MS mode, while 3,000 shots were accumulated for spectra in MS/MS mode. Up to ten of the most intense ion signals with a signal to noise ratio above 20 were selected as the precursors for MS/MS. External calibration in MS mode was performed using a mixture of four peptides: des-Arg1-Bradykinin (m/z = 904.47), angiotensin I (m/z = 1,296.69), Glu1-brinopeptide B (m/z = 1,570.68) and ACTH (18-39) (m/z = 2,465.20). MS/MS spectra were externally calibrated using known fragment ion masses observed in the MS/MS spectrum of angiotensin I. A search of the MS/MS database was performed against the NCBInr databases using Mascot so ware (www.matrixscience.com).
e search parameters included the allowance of two missed tryptic cleavages and non-xed modi cations of methionine, tryptophan, histidine (oxidation) and cysteine (carbamidomethylation and propionamide). e peptide per sample plate (pps) and peptide per well (ppw) les were generated from the raw (or native) MS data according to the following parameters using Data Explorer So ware (Applied Biosystems). For MS1: mass range, 900-4,000 Da; peak density, 15 peaks per 200 Da; signal-to-noise ratio, 20; minimum area, 100 μm 2 ; maximum peaks per spot, 60. For MS2: mass range, 60 or 20 Da for the precursor; peak density, 55 peaks per 200 Da; signal-to-noise ratio, 2; minimum area, 10; maximum peaks per precursor, 200. e protein identi cations based on the MS/ MS data were validated using Sca old 2 so ware (Proteome So ware Inc., Portland, OR).
e identi ed proteins were accepted if they possessed >90.0% probability, as speci ed by the Peptide Prophet algorithm [15] . Protein probabilities were assigned by the Protein Prophet algorithm [16] .
Bioinformatics analysis
A BLAST search of the genome project databases was performed for Leishmania major (http://www.genedb.org/ Homepage/Lmajor), Trypanosoma brucei brucei (http:// www.genedb.org/Homepage/Tbruceibrucei427) and Homo sapiens (http://www.ncbi.nlm.nih.gov/genome/) to nd annotated sequences to all T. cruzi polypeptides identi ed in this study. Alternatively, to suggest a possible function of the identi ed hypothetical T. cruzi proteins, another BLAST analysis of the whole NCBI database was performed. e function and localisation of the polypeptides was predicted using Gene Ontology (GO, http://www.geneontology.org/), the Kyoto Encyclopaedia of Genes and Genomes (KEGG, http://www.genome.jp/kegg/), Uniprot (http:// www.uniprot.org/) and SwissProt (http://www.expasy.org/ tools/). e high hit sequences (E value ≤ 10 -50 ) of L. major, T. brucei and H. sapiens were aligned to the identi ed T. cruzi proteins using the multiple sequence alignment (MSA) program T-Co ee (European Bioinformatics Institute, Cambridge, UK). Di erent sequences (≥20 amino acids) observed between the T. cruzi and H. sapiens proteins were classi ed as non-homologous. Motif prediction analysis was performed using query sequences in NCBI Conserved Domain (http://www.ncbi.nlm.nih.gov/cdd) and ScanProsite tools (http://www.expasy.ch/tools/scanprosite/).
Results
e protein preparation and two-dimensional electrophoresis conditions for T. cruzi epimastigote samples have been previously established (Menna-Barreto et al., 2010), allowing for high reproducibility and e ective spot identi cation with excellent ion scores. In the colloidal Coomassie-stained gel (pH 4-7), 600 spots were detected and 117 most intensely staining spots were identi ed as 78 distinct proteins ( Figure  1 ). e complete list of the identi ed proteins is shown in supplementary Table S1 . Between these identi ed proteins, Figure 1 . Colloidal Coomassie Blue staining of T. cruzi epimastigotes (Y strain). 2-DE was performed with 500 μg of soluble protein using pH 4-7 IPG strips (18 cm), followed by 12% SDS-PAGE. Circles and numbers represent proteins and refer to the spot identi cation in Table  S1 (supplementary data). een novel polypeptides not previously addressed in any T. cruzi proteome investigation were showed. ese proteins are: mitochondrial heat shock, hypothetical proteins 1-6, glycosyl transferase family 2, metallocarboxypeptidase chain A, protein of unknown function DUF909, unnamed protein product, chaperonin GroEL, twin-arginine translocation pathway signal serine carboxypeptidase, conserved hypothetical protein and Sorting nexin GRD19 homolog. Interestingly, among these molecules, only a few had been described at the protein (3/15) or transcriptional (1/15) level. Most of these proteins were predicted (10/15) or even inferred by homology (1/15); this is the rst description of their expression in this protozoan.
Here, we showed a map of the post-translational modi cations revealed by staining 2-D gels with two di erent uorescent dyes for phosphoproteins and glycoproteins. ree hundred and eighty-four phosphoproteins (Pro-QDiamond) and 34 glycoproteins spots (Pro-Q-Emerald) were detected. However, only 34 (Pro-Q-Diamond) and 24 (Pro-Q-Emerald) spots could be linked to their corresponding protein, resulting in 22 and 15 di erent proteins, respectively (Figures 2A,B) .
e complete list of identi ed proteins is presented in supplementary Table S2 . To further investigate the two most common PTMs, phosphorylation and glycosylation, 2D gels were stained with Pro-Q-Diamond and Pro--Emerald, respectively, leading to 31 di erent identi cations, as shown in Table S2 . A general evaluation of the previous status of the phosphoproteins and glycoproteins identi ed here demonstrated a similar percent distribution of proteins described as predicted (11/31), inferred by homology (8/31) or even detected at the protein (5/31) or transcriptional (5/31) level, reinforcing the necessity and relevance of further high throughput studies on post-translational modi cations in protozoan pathogens, including T. cruzi. Surprisingly, some proteins were only identi ed as phosphoproteins (4.7%) and glycoproteins (0.5%) a er the use of a speci c uorescent dye ( Figure 3A ), which could be explained by an increase in colloidal Coomassie sensitivity when the staining was performed a er the labelling of the samples with uorescent dyes (data not shown).
e percentage of peptides identi ed through each of the three staining protocols varied: colloidal Coomassie staining led to 83.2% of the peptide identi cations, followed by Pro-Q-Diamond staining (8.9%) and Pro-Q-Emerald staining (4.7%). Only 3.2% of spots were identi ed by all of the three protocols ( Figure 3) . A mascot search of the whole NCBI Figure 2 . Pro-Q-Diamond (A) and Pro-Q-Emerald (B) staining of T. cruzi epimastigotes (Y strain). 2-DE was performed with 500 μg of soluble protein using pH 4-7 IPG strips (18 cm), followed by 12% SDS-PAGE. Circles and numbers represent proteins and refer to the spot identi cation in Table S2 (supplementary data). database evidenced that 82.2% of the identi ed proteins were speci c to T. cruzi, being a low percentage of identi cations (6.7%) corresponded to highly conserved proteins that were not associated with any speci c organism (data not shown). Compared to the L. major, T. brucei and H. sapiens genome databases, a high percentage of proteins were conserved in trypanosomatids; 92% of the identi ed proteins shared high sequence identity or similarity to H. sapiens. A low percentage of polypeptides (8%) did not appear to be homologous to any human peptide sequence ( Figure 3B) . A er the MSA analysis, 21 candidates were selected as potential drug targets by their low similarity to H. sapiens proteins. Among those proteins, 10 presented no identity to humans, which two were excluded as potential targets, and another 11 proteins presented promising sequence fragment with no identity to human proteins (Table 1) .
e motif prediction analysis showed that these sequence fragments represent sites of post -translational modi cations, such as phosphorylation, amidation, N-glycosylation and/or N-myristoylation.
Among all of the T. cruzi identi cations, 10 hypothetical proteins were found and numbered from 1 to 10 ( Figures 1 and 2A , Tables S1 and S2). A BLAST analysis of the whole NCBI database suggested the possible predicted protein functions, as shown in Table S3 . Localisation and functional analysis demonstrated that cytosolic proteins were the most abundant (41%), followed by proteins localised in the mitochondrion (15.4%), nucleus (9.0%), glycosome (5.1%), plasma membrane (3.8%), endoplasmic reticulum (2.6%), agellum (2.6%), reservosome (1.3%), cytoskeleton (1.3%) and proteasome (1.3%) under our experimental conditions ( Figure 4A ). In relation to predicted function, the most common pathway was the protein metabolism pathway, represented by the protein biosynthesis pathway (26.9%) and degradation pathway (19.2%), equalling 46.1% of the total sequences. e other proteins were grouped into pathways including energetic metabolism (23.1%), motility and intracellular tra cking (9%), redox balance (2.6%), cell signalling (2.6%), lipid metabolism (1.3%), nucleic acid regulation (2.6%) and the polyamine pathway (2.6%) ( Figure 4B ).
Discussion
More than one century a er the discovery of Chagas´disease, this illness still represents a serious health problem not only for its endemic region but also for developed countries due to the immigration of infected people. e current treatment of the disease is unsatisfactory, and an e cient prophylactic therapy is required, reinforcing the importance of designing new drug candidates for treatment and identifying alternative drug targets that are speci c for the parasite [3, 4, 17] . In this work, we provide additional information on the proteomic map of T. cruzi epimastigotes through the use uorescent dyes and bioinformatics analysis.
Over the last decade, the proteomic map of di erent strains of T. cruzi epimastigotes has been extensively investigated, including clone Dm28c and the sylvan isolates [7] [8] [9] [10] [18] [19] [20] [21] [22] [23] . About Y strain epimastigotes, the unique large-scale protein investigation was performed in 2008 in order to characterise the molecules involved in the resistance and susceptibility of these parasites to the current chemotherapeutic agent benznidazole. Fi y-ve proteins were identi ed, with approximately 10% hypothetical proteins [10] , similar percentage to that observed in the present work. Here, also employing the 2-D gels followed by MALDI-TOF/TOF analysis, it was identi ed 78 distinct proteins approximately 30% more proteins.
Among the 10 trypanosomatid-speci c proteins, each one represents a good candidate for drug intervention due to [24] , related to ROS balance. 24-C-methyltransferase participates in ergosterol biosynthesis [25] , directly involved in the parasite´s plasma membrane uidity. Calpain is a protease associated to the protozoa di erentiation and infectivity [26, 27] . A predicted dehydrogenase was better characterised in 2006 as prostaglandin F2 alpha synthase [28] , being related to detoxi cation processes. Phosphoenolpyruvate carboxykinase is a key enzyme in gluconeogenesis [29] . Nucleoside phosphorylase participates in purine metabolism, being fundamental for nucleoside recovery a er nucleotide degradation [30, 31] . HslVu is a subunit of a large complex that degrades misfolded proteins called the proteasome [32] . I/6 autoantigen is a calcium-binding microtubule-associated protein responsible for crosslinking microtubule laments and involved mitosis, vesicle tra cking and other events [33] . e last two candidates are involved in bioenergetics and for di erent reasons are not promising targets. P28 is a predicted pyruvate kinase superfamily protein that presents almost a half of the identical sequence of pyruvate kinase.
e high similarity of pyruvate kinase to the corresponding mammalian protein led us to exclude P28 as a potential molecular target for novel trypanocidal drugs. Cytochrome c oxidase is a fundamental enzyme of respiratory electron transport chain [34] . Despites the di erences between human and T. cruzi complex IV, the presence of alternative oxidases in the parasite [35] , suggests that this protein is not a good target for drug design.
Comparison of the identi ed T. cruzi epimastigote proteins with other trypanosomatid and human sequences allowed for the selection of 21 proteins as potential drug targets, among which 10 displayed no hits in a BLAST analysis against human database and these trypanosomatid-speci c proteins will further discussed here. e other 11 proteins presented stretches of more than 20 amino acids that did not align to the respective human sequences in the MSA, but the possibilities of misalignment due to the presence of multimeric proteins indicated that better algorithms must be used in order to increase the con dence.
PTMs of proteins are well characterised to be functionally important for various physiological and pathological processes, such as signal transduction and cellcell recognition [36] . Until this study, Y strain epimastigotes´ glycoprotein content has not been assessed. In 2006, the glycoproteome of trypomastigotes (Brazil strain) was published [37] , demonstrating the presence of 31 glycosylated proteins, absent here. Because glycosylation could be fundamental for host cell recognition of the protozoa, it is expected that the infective parasite form presented a di erent pool of molecules in the relation to the insect form. Nakayasu and co-workers (2009) preliminarily assessed phosphoproteome of Y strain epimastigotes by LC-MS/MS [38] , identifying 107 proteins that was not found here. Surprisingly, 19 of the phosphoproteins identi ed here by uorescent staining of 2D gels and MALDI-TOF/TOF were not in the previous Y strain identi cation list. ese molecules are heat shock-like 85, alpha tubulin, peroxiredoxin, para agellar rod protein 1D, glutamine synthetase, actin, pyrroline-5-carboxylate synthetase, 14-3-3 protein, chain A of spermidine synthase, enolase 1, eukaryotic initiation factor 5a, chaperonin containing T-complex protein, 80 kDa prolyl oligopeptidase, aminoacylase, proteasome beta 3 subunit and hypothetical proteins 7, 8, 9 and 10.
Concluding remarks
Despite many previous e orts to describe the proteome of epimastigotes, new molecules are still being identi ed in this proliferative form of T. cruzi. Our data could provide new insights into the signalling networks of this protozoan, supplying additional information about its cell biology. Here, it was identi ed 8 promising good candidates for drug intervention, being necessary a validation in the mammalian forms of parasite.
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